Tomás Pascual, Medical oncologist in Breast Cancer at Hospital Clinic, shared a post on X about a recent paper by Guillermo Villacampa et al. published in Cancer Treatment Reviews:

“New Publication. We conducted a systematic review and meta-analysis evaluating the combination of ADCs and ICIs in solid tumors. Findings show comparable safety to monotherapy, but increased risks for ILD/pneumonitis.”

“Safety and efficacy of antibody-drug conjugates plus immunotherapy in solid tumours: A systematic review and meta-analysis”

Authors: Guillermo Villacampa, Pablo Cresta Morgado, Lorenzo Carità, Victor Navarro, Tomas Pascual, Rodrigo Dienstmann.

Tomás Pascual: Systematic review and meta-analysis of ADCs and ICIs in solid tumors

More posts featuring Tomás Pascual.

Tomás Pascual is a Medical Oncologist at Hospital Clínic de Barcelona and a clinical scientist at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS). He serves as a board member of the SOLTI Breast Cancer Research Group and is the former Chief Scientific Officer of SOLTI.